TY - JOUR
T1 - Cardiovascular effects of losartan and its relevant clinical application
AU - Xu, Feichao
AU - Mao, Caiping
AU - Hu, Yali
AU - Rui, Can
AU - Xu, Zhice
AU - Zhang, Lubo
N1 - The renin-angiotensin system (RAS) plays an important role in the homeostasis of the cardiovascular system and in the development of cardiovascular diseases. An abnormal expression or over activation of the local RAS in the heart and vasculature system is one of the most common mechanisms in pathophysiological processes in cardiovascular diseases.
PY - 2009
Y1 - 2009
N2 - The renin-angiotensin system (RAS) plays an important role in the homeostasis of the cardiovascular system and in the development of cardiovascular diseases. An abnormal expression or over activation of the local RAS in the heart and vasculature system is one of the most common mechanisms in pathophysiological processes in cardiovascular diseases. This also provides a basis for medical prevention and treatments using chemical approaches. Losartan is a selective nonpeptite antagonist against type 1 angiotensin II receptors (AT1R), and has been applied in medical treatments of a variety of cardiovascular diseases, including essential hypertension. This article reviews direct and indirect cardiovascular effects of losartan on the heart and blood vessels. It summarizes the chemical basis of AT1R for the action site of losartan, focuses on the mechanisms underlying the action of losartan involved in both the heart and vasculature, and reviews the information that may be helpful in the development of new chemical candidates or approaches in the war against cardiovascular diseases.
AB - The renin-angiotensin system (RAS) plays an important role in the homeostasis of the cardiovascular system and in the development of cardiovascular diseases. An abnormal expression or over activation of the local RAS in the heart and vasculature system is one of the most common mechanisms in pathophysiological processes in cardiovascular diseases. This also provides a basis for medical prevention and treatments using chemical approaches. Losartan is a selective nonpeptite antagonist against type 1 angiotensin II receptors (AT1R), and has been applied in medical treatments of a variety of cardiovascular diseases, including essential hypertension. This article reviews direct and indirect cardiovascular effects of losartan on the heart and blood vessels. It summarizes the chemical basis of AT1R for the action site of losartan, focuses on the mechanisms underlying the action of losartan involved in both the heart and vasculature, and reviews the information that may be helpful in the development of new chemical candidates or approaches in the war against cardiovascular diseases.
KW - Angiotensin II
KW - Cardiac remodeling
KW - Heart
KW - Hypertension
KW - Losartan
KW - Renin-angiotensin system
UR - https://www.scopus.com/pages/publications/70450206832
UR - https://www.scopus.com/pages/publications/70450206832#tab=citedBy
UR - https://www.mendeley.com/catalogue/b9abbf57-f066-3a5f-b211-68d07a3c0987/
U2 - 10.2174/092986709789178046
DO - 10.2174/092986709789178046
M3 - Article
C2 - 19747137
SN - 0929-8673
VL - 16
SP - 3841
EP - 3857
JO - Current Medicinal Chemistry
JF - Current Medicinal Chemistry
IS - 29
ER -